**Correction to:** *npj Parkinson\'s Disease* (2017); doi:10.1038/s41531-016-0003-z; Published online 09 January 2017Table 1Baseline demographics of participantsVariablePTA^a^TAU^b^All(*N*  =  94)(*N*  =  107)(*N*  =  201)Mean (SD)Mean (SD)Age at screening (year)59.86 (9.13)60.71 (10.26)60.31 (9.73)Gender Female34 (36.2%)45 (42.1%)79 (39.3%) Male60 (63.8%)62 (57.9%)122 (60.7%)Number of comorbidities1.39 (1.66)1.32 (1.59)1.35 (1.62)Parkinson's disease duration (years)5.47 (4.18)5.47 (4.89)5.47 (4.56)Morisky Medication Adherence Scale (MMAS-8^c^)6.03 (1.57)5.82 (1.48)5.92 (1.52)Quality of life (PDQ-39)154.53 (27.98)151.43 (27.70)152.88 (27.81)Patient-Centered Questionnaire for Parkinson's Disease (PCQ-PD)1.91 (0.53)1.93 (0.51)1.92 (0.52)Non-Motor Symptoms Questionnaire (NMSQuest)10.16 (5.42)10.24 (5.24)10.20 (5.31)Hospital Anxiety Rating Scale (HADSa)5.49 (3.95)6.16 (4.14)5.85 (4.06)Hospital Depression Rating Scale (HADSd)5.15 (3.68)5.14 (3.73)5.14 (3.70)Beliefs about Medication Questionnaire (BMQ)51.83 (9.48)51.93 (8.09)51.88 (8.74)Number who need help with their medication (*n*)192746^a^ *PTA* Parkinson's tracker app^b^ Treatment as usual^c^ Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A license agreement is available from: Donald E. Morisky, MMAS Research (MORISKY) 14725 NE 20th St. Bellevue, WA 98007; dmorisky\@gmail.com Table 3Change in mean scores on the MMAS-8 between PTA and TAU groups at 16 weeks (intention-to-treat population)VariableStatistics/categoryPTA^a^TAU^b^AllMorisky Medication Adherence Scale (MMAS-8)*n*6890158Mean (SD)6.30 (1.52)5.74 (1.53)5.98 (1.55)GLM analysis^c^Difference and 95%CI0.39 (0.04,0.74)*P*-value0.0304Covariate adjusted GLM analysis^d^Difference and 95%CI0.38 (0.03,0.73)*P*-value0.0331^a^ *PTA* Parkinson's tracker app^b^ Treatment as usual^c^ *GLM* generalised linear model^d^ Age, gender, number of co-morbidities, PD duration were used as covariates. Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A license agreement is available from: Donald E. Morisky, MMAS Research (MORISKY) 14725 NE 20th St. Bellevue, WA 98007; dmorisky\@gmail.com

In the original version of this article the copyright notice was missing from Tables [1](#Tab1){ref-type="table"} and [3](#Tab2){ref-type="table"}. This has now been added alongside the three relevant references inserted as refs. 21--23. The correction has been published and is appended to both the HTML and PDF versions of this paper. The errors have been fixed in the paper.

New references inserted:

Participants in the PTA group (n = 68) showed an improvement in MMAS-8.^21,22,23^
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